Dr. Lagares is a serial scientist-entrepreneur with more than 15 years of experience in academic medicine, pharma and biotech. He is currently the Founder & CEO of Zenon Biotech and the co-founder of Mediar Therapeutics, biotech companies in the Boston area developing novel drugs to treat cancer, aging and fibrosis. The molecular targets that led to the foundation of these NewCos were identified at his academic research laboratory at Harvard University and the Massachusetts General Hospital. His innovative research and strategic vision about the future treatment of cancer and fibrotic diseases have been supported with multi-million dollar investment from VCs, federal funding, industry-sponsored research, and non-profit Foundation grants.Dr. Lagares holds a Ph.D. in Medical Research and completed his postdoctoral training at Harvard Medical School. Before becoming Zenon’s CEO, he was a Professor of Medicine at Harvard University. He is an Executive MBA candidate in Entrepreneurship and Innovation at the MIT Sloan School of Management.